About this trial
The goal of this nationwide multicenter observational study is to comprehensively investigate the severity of Small Vulnerable Newborns (SVN) issues across China and to propose further preventive and intervention measures. The primary aim is to provide a thorough description of SVN problems using a unified definition and framework, and to develop targeted prevention strategies.
Participating centers across the country will collect clinical data on vulnerable newborns under their care and complete detailed questionnaires to support this research.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Newborns diagnosed as vulnerable infants at the participating hospitals between January 1 and December 31, 2024;
Diagnosed as small for gestational age (SGA): birth weight below the 10th percentile for infants of the same gestational age and sex;
Preterm infants: gestational age less than 37 weeks;
Low Birth Weight (LBW) infants: birth weight less than 2,500 grams.
Disqualifiers
Incomplete medical records due to missing data preventing comprehensive case evaluation.
Trial population
Small vulnerable newborns admitted to major hospitals across various regions of China in 2024
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of small vulnerable newborns
Mortality rate
Secondary outcomes
Incidence of complications in small vulnerable newborns
Including mechanical ventilation, bronchopulmonary dysplasia, congenital heart defects, congenital gastrointestinal malformations, retinopathy of prematurity, periventricular-intraventricular hemorrhage, periventricular leukomalacia, neonatal sepsis, and neonatal bacterial meningitis.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.